newsfilter
← Latest News
FDA Approved Drugs·

Approval of Tagrisso, Nda #208065 (Labeling)

Approval Date: 09/14/2026; Drug Name: Tagrisso, Nda #208065; Active Ingredients: OSIMERTINIB MESYLATE; Company: Astrazeneca; Submission Status: Approval; Submission Classification: Labeling; Application Number: 208065

Company
ASTRAZENECA
Keywords
ASTRAZENECA